Tau hyperphosphorylation and P-CREB reduction are involved in acrylamide-induced spatial memory impairment: Suppression by curcumin

Brain Behav Immun. 2018 Jul:71:66-80. doi: 10.1016/j.bbi.2018.04.014. Epub 2018 Apr 26.

Abstract

Acrylamide (ACR) is an axonal toxicant that produces peripheral neuropathy in laboratory animals and humans. Epidemiological study found that diet ACR exposure was associated with a mild cognitive decline in men. However, limited information is available as regards its potential and underlying mechanism to cause memory alterations. Curcumin is a polyphenol with neuroprotective and cognitive-enhancing properties. In this study, we aimed to investigate the mechanism of ACR-induced spatial memory impairment and the beneficial effect of curcumin. ACR exposure at 10 mg/kg/d for 7 weeks caused slight gait abnormality and spatial memory deficits, which was associated with an activation of glial cells, a reduction of phosphorylated cAMP response elements binding protein (P-CREB) and an aggregation of hyperphosphorylated tau including p-tau (Ser262), AT8 (p-tau Ser202/Thr205) and PHF1 (p-tau Ser396/404) in the hippocampus and cortex. ACR markedly regulate the expression of glycogen synthase kinase-3β (GSK-3β) and cyclin-dependent kinase-5 (cdk5) to accelerate tau hyperphosphorylation. ACR inhibited the protein phosphatase 2A (PP2A) and lysosomal protease cathepsin D to decrease the p-tau dephosphorylation and degradation. The P-CREB and brain derived neurotrophic factor (BDNF) were significantly decreased by ACR. The upstream signalings of P-CREB, extracellular signal-related kinase (ERK) and Akt were markedly inhibited. The protein kinase RNA-like endoplasmic reticulum kinase (PERK) -eukaryotic initiation factor-2α (eIF2α) - activating transcription factor 4 (ATF4) signaling which negatively regulate memory processes by suppressing CREB was activated by ACR. Curcumin alleviated ACR-induced spatial memory impairment through reversing tau abnormalities and P-CREB reduction in the hippocampus. These results offered deeper insight into the mechanisms of and presented a potential new treatment for ACR-induced neurotoxicity.

Keywords: Acrylamide; CREB reduction; Curcumin; PERK- eIF2α- ATF4; Spatial memory impairment; Tau phosphorylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylamide / pharmacology
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Axons / metabolism
  • Brain-Derived Neurotrophic Factor / metabolism
  • Cathepsin D / metabolism
  • Curcumin / pharmacology*
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Cyclic AMP Response Element-Binding Protein / physiology
  • Cyclin-Dependent Kinase 5 / metabolism
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Hippocampus / metabolism
  • MAP Kinase Signaling System / physiology
  • Male
  • Memory Disorders / metabolism
  • Neurons / metabolism
  • Phosphorylation
  • Protein Phosphatase 2 / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects
  • Spatial Memory / drug effects*
  • Spatial Memory / physiology
  • tau Proteins / metabolism*

Substances

  • Amyloid beta-Peptides
  • Brain-Derived Neurotrophic Factor
  • Creb1 protein, rat
  • Cyclic AMP Response Element-Binding Protein
  • tau Proteins
  • Acrylamide
  • Cyclin-Dependent Kinase 5
  • Glycogen Synthase Kinase 3 beta
  • Protein Phosphatase 2
  • Cathepsin D
  • Curcumin